Published in Arterioscler Thromb Vasc Biol on February 01, 2000
Increased influence of genetic variation on PON1 activity in neonates. Environ Health Perspect (2003) 2.36
Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet (2001) 1.85
Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ Cardiovasc Genet (2008) 1.76
Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes. Environ Health Perspect (2010) 1.62
Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.50
Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology (2010) 1.30
Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor. Biochem J (2003) 1.30
Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol Appl Pharmacol (2008) 1.21
Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-exposed agricultural pesticide handlers. Environ Health Perspect (2009) 1.14
Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact (2010) 1.09
Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.01
Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicology (2012) 0.99
Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1). Environ Health Perspect (2005) 0.96
The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal (2011) 0.95
Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis. PLoS One (2011) 0.95
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics (2013) 0.91
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol (2008) 0.90
The genetics of vascular complications in diabetes mellitus. Cardiol Clin (2010) 0.85
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue. J Lipid Res (2010) 0.85
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene (2015) 0.83
Association between paraoxonase gene and stroke in the Han Chinese population. BMC Med Genet (2013) 0.83
Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL. J Lipid Res (2012) 0.83
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease. Arch Med Sci (2013) 0.83
Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South. Pharmacogenet Genomics (2011) 0.83
Novel associations of nonstructural Loci with paraoxonase activity. J Lipids (2012) 0.83
Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis. Front Pharmacol (2011) 0.82
Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration. Am J Ophthalmol (2009) 0.82
Paraoxonase 1 polymorphism and prenatal pesticide exposure associated with adverse cardiovascular risk profiles at school age. PLoS One (2012) 0.82
Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environ Health Prev Med (2011) 0.81
Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease. Gut (2006) 0.81
Biomarkers of sensitivity and exposure in Washington state pesticide handlers. Adv Exp Med Biol (2010) 0.79
Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects. Lipids Health Dis (2013) 0.79
Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease. Dig Dis Sci (2007) 0.78
Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease. J Community Genet (2011) 0.78
Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD). Age (Dordr) (2012) 0.78
Species differences in paraoxonase mediated hydrolysis of several organophosphorus insecticide metabolites. J Toxicol (2015) 0.76
Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype. Toxicol Lett (2014) 0.76
Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers. Ann Saudi Med (2011) 0.75
Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study. J Transl Med (2016) 0.75
Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease. Int J Vasc Med (2016) 0.75
Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms. Open Biochem J (2017) 0.75
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Energy expenditure and substrates oxidative patterns, after glucose, fat or mixed load in normal weight subjects. Eur J Clin Nutr (1997) 1.39
Toxicologic evaluation of FK 506. Transplant Proc (1990) 1.36
Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. J Mol Med (Berl) (2001) 1.18
Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr (1992) 1.17
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis (1999) 1.12
Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol (1997) 1.12
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. J Lipid Res (2001) 1.12
Persistent pupillary membrane in basenji dogs. Vet Rec (1991) 1.08
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis (2001) 1.08
2-Amino-4-phosphonobutyric acid as a glutamate antagonist on locust muscle. Nature (1976) 1.06
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic sera. Eur J Immunol (1982) 1.02
Factors affecting the in-vitro development to blastocysts of bovine oocytes matured and fertilized in vitro. J Reprod Fertil (1991) 1.00
Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J Biol Chem (2000) 0.94
Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes. Diabetologia (1994) 0.89
Monoclonal antibodies directed against the neurotransmitter binding site of nicotinic acetylcholine receptor. FEBS Lett (1980) 0.89
Heterogeneity in the properties of the trypanolytic factor in normal human serum. Mol Biochem Parasitol (1994) 0.87
Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats. J Cell Biochem (2005) 0.84
Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. Am J Clin Nutr (2000) 0.83
Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1. Diabetologia (2003) 0.83
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia. Nutr Metab Cardiovasc Dis (2004) 0.81
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas (1999) 0.81
European Lipoprotein Club: report of the 20th annual conference, Tutzing, 8-11 September 1997. Atherosclerosis (1998) 0.81
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus. Metabolism (2001) 0.81
Isolation of a glutaminergic receptor fraction from locust muscle. Biochem Soc Trans (1977) 0.80
Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I. Endocrinology (2001) 0.80
The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients. Diabetologia (2001) 0.79
The apolipoprotein epsilon2 allele and the severity of coronary artery disease in Type 2 diabetic patients. Diabet Med (2001) 0.79
Apolipoprotein E polymorphisms and mortality in Italian type 2 diabetic patients. Eur J Clin Invest (2003) 0.79
Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Diabetes Metab (2001) 0.78
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care (1995) 0.78
Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis (1986) 0.77
Toxicological studies on 1-substituted-indazole-3-carboxylic acids. Chemotherapy (1981) 0.77
Characterization of iodinated derivatives of alpha-bungarotoxin. Hoppe Seylers Z Physiol Chem (1980) 0.77
Effects of morphine sulphate on pituitary-testicular morphology of rats. Toxicol Lett (1980) 0.77
Canine pituitary-testicular function in relation to toxicity testing. Toxicology (1979) 0.76
Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells. Eur J Neurosci (1996) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
Lipoprotein(a) and retinopathy in IDDM and NIDDM patients. Diabetes Care (1997) 0.76
Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients. Nutr Metab Cardiovasc Dis (2009) 0.76
High-resolution two-dimensional protein electrophoresis of pathological plasma/serum. Appl Theor Electrophor (1991) 0.76
From biopsy to automatic diagnosis. Schweiz Med Wochenschr (1990) 0.75
Assessment of testicular toxicity in laboratory animals. Environ Health Perspect (1978) 0.75
The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients. Am J Hum Genet (1997) 0.75
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr (1997) 0.75
Talking health: using talkback radio for health promotion. Community Health Stud (1987) 0.75
The influence of metabolic control on very low density lipoprotein composition in hypertriglyceridemic type II diabetics. A study using heparin-sepharose chromatography. Metabolism (1988) 0.75
Testicular responses of rats and dogs to cyclohexylamine overdosage. Food Cosmet Toxicol (1981) 0.75
Toxicology studies of linear alkylbenzene sulphonate (LAS) in rhesus monkeys. I. Simultaneous oral and subcutaneous administration for 28 days. Toxicology (1978) 0.75
Effects of culture duration and time of gonadotropin addition on in vitro maturation and fertilization of red deer (Cervus elaphus) oocytes. Theriogenology (1991) 0.75
Preparative isoelectrofocusing and high resolution 2-dimensional gel electrophoresis for concentration and purification of proteins. Appl Theor Electrophor (1991) 0.75
11C distribution in dogs visualized in situ after intravenous 11C-cyanide in high specific activity. Nucl Med (Stuttg) (1973) 0.75
Anti-inflammatory agents and hypoproteinaemia. Vet Rec (1980) 0.75
Lipoprotein complexes in human cerebrospinal fluid. Schweiz Arch Neurol Psychiatr (1993) 0.75
Age-related variations in the testes and prostate of beagle dogs. Toxicology (1979) 0.75
[Molecular pathophysiology of familial hypercholesterolemia]. Pol Tyg Lek (1985) 0.75
[Relation between HDL cholesterol and fasting glycemia in a normal population and a diabetic group]. Schweiz Med Wochenschr (1984) 0.75
Native immunoaffinity-isolated apolipoprotein E-containing high-density lipoprotein particles inhibit platelet aggregation. Biochem Soc Trans (1996) 0.75
The oral toxicity of 1-amino-3-chloro-propanol hydrochloride (CL 88236) in rats. Toxicology (1978) 0.75
Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients. Diabetes Care (1999) 0.75
A novel high-density lipoprotein particle and associated protein in rat plasma. Biochim Biophys Acta (1990) 0.75
High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition. Atherosclerosis (1988) 0.75
Biochemical observations on beagle dog semen. Vet Rec (1979) 0.75
Partial purification of lymphoblasts after in vitro immunization increases the yield in Ig-producing hybridomas. J Immunol Methods (1987) 0.75
Actin stress fiber content of regenerated endothelial cells correlates with intramural retention of intermediate plus low density lipoproteins in rat aorta after balloon injury. Atherosclerosis (1989) 0.75
Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles. Atherosclerosis (1998) 0.75
[Classification of hyperlipoproteinemia in the light of advances in pathogenetic studies]. Pol Tyg Lek (1985) 0.75
Serial percutaneous testicular biopsy in the Beagle dog. J Small Anim Pract (1979) 0.75
Pancreatic atrophy in young Beagle dogs. Vet Pathol (1980) 0.75
Quantitative assessment of spermatogenesis in rats given 1-amino-3 chloro-2 propanol hydrochloride (CL 88, 236). Toxicol Lett (1980) 0.75
[Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes]. Schweiz Med Wochenschr (1989) 0.75
Choriocarcinoma with intact pregnancy. Report of a case with review of the literature. Aust N Z J Obstet Gynaecol (1968) 0.75
Ambulatory medical care data: Milwaukee Model Cities survey of outpatient utilization. Med Care (1973) 0.75
Quantitative aspects of spermatogenesis in rats and dogs after repeated hexachlorophene treatment. Toxicol Lett (1980) 0.75
Epitope expression in purified and lipid-bound forms of human apoprotein A-I. Adv Exp Med Biol (1987) 0.75
Distribution of cholesterol within high density lipoproteins fractionated by immunoaffinity chromatography. Adv Exp Med Biol (1991) 0.75
A non-competitive enzyme-linked immunosorbent assay for measuring human plasma apolipoprotein B levels. Clin Chim Acta (1985) 0.75
Immunological confirmation of the presence of NA1/NA2 (cytolysis inhibitor) in cerebrospinal fluid. Schweiz Arch Neurol Psychiatr (1991) 0.75
Reversible suppression of spermiogenesis in beagle dogs following overdosage with the narcotic analgesic cogazocine lactate. Toxicology (1980) 0.75
Lack of cross-reactivity of a monoclonal antibody against the neurotransmitter site of Torpedo nicotinic acetylcholine receptor with muscle receptors from several sources. Mol Immunol (1983) 0.75
Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients. Diabet Med (2004) 0.75
The intravenous toxicity of dibekacin sulphate (DKB) to female beagle dogs. Jpn J Antibiot (1980) 0.75
Health promotion or community development? Health communication or DevCom? Who's confused? Media Asia (1998) 0.75
Up-regulation of clusterin (apolipoprotein J) and apolipoprotein E in cultured rat spinal cord neurones. Schweiz Arch Neurol Psychiatr (1994) 0.75
Evidence for sialic acid on the nicotinic acetylcholine receptor from Torpedo marmorata. Neurochem Int (1983) 0.75
Phenotyping of apolipoprotein E using immobilized pH gradient gels for one-dimensional and two-dimensional separations. Electrophoresis (1995) 0.75
Guidelines for conducting rapid participatory appraisals of community health needs in developing countries: experience from Tulikup, Bali. Asia Pac J Public Health (2006) 0.75